nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—breast cancer—bone cancer	0.262	0.606	CtDrD
Vinorelbine—TUBB4B—bone cancer	0.225	0.516	CbGaD
Vinorelbine—TUBB2A—bone cancer	0.187	0.428	CbGaD
Vinorelbine—lung cancer—bone cancer	0.17	0.394	CtDrD
Vinorelbine—CYP3A4—bone cancer	0.0245	0.056	CbGaD
Vinorelbine—Vinblastine—TUBB4B—bone cancer	0.000753	0.209	CrCbGaD
Vinorelbine—Vincristine—TUBB4B—bone cancer	0.000741	0.206	CrCbGaD
Vinorelbine—TUBB2B—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000655	0.00928	CbGpPWpGaD
Vinorelbine—TUBB6—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000655	0.00928	CbGpPWpGaD
Vinorelbine—TUBB4B—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.000651	0.00923	CbGpPWpGaD
Vinorelbine—TUBB2B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000636	0.00901	CbGpPWpGaD
Vinorelbine—TUBB6—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000636	0.00901	CbGpPWpGaD
Vinorelbine—TUBB3—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000632	0.00896	CbGpPWpGaD
Vinorelbine—Vinblastine—TUBB2A—bone cancer	0.000624	0.174	CrCbGaD
Vinorelbine—TUBB4A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.000623	0.00883	CbGpPWpGaD
Vinorelbine—TUBB3—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000614	0.0087	CbGpPWpGaD
Vinorelbine—Vincristine—TUBB2A—bone cancer	0.000614	0.171	CrCbGaD
Vinorelbine—TUBB4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.000605	0.00857	CbGpPWpGaD
Vinorelbine—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000604	0.00856	CbGpPWpGaD
Vinorelbine—TUBB4B—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.000601	0.00852	CbGpPWpGaD
Vinorelbine—TUBB1—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000599	0.00848	CbGpPWpGaD
Vinorelbine—TUBB1—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000581	0.00824	CbGpPWpGaD
Vinorelbine—TUBB4A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000538	0.00762	CbGpPWpGaD
Vinorelbine—TUBB4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000522	0.0074	CbGpPWpGaD
Vinorelbine—TUBB4B—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000492	0.00697	CbGpPWpGaD
Vinorelbine—Vinblastine—JUN—bone cancer	0.000486	0.135	CrCbGaD
Vinorelbine—TUBB4B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000478	0.00677	CbGpPWpGaD
Vinorelbine—TUBB6—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000471	0.00667	CbGpPWpGaD
Vinorelbine—TUBB2B—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000471	0.00667	CbGpPWpGaD
Vinorelbine—TUBB3—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000455	0.00644	CbGpPWpGaD
Vinorelbine—TUBB2A—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.00044	0.00624	CbGpPWpGaD
Vinorelbine—TUBB1—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000431	0.0061	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000429	0.00608	CbGpPWpGaD
Vinorelbine—TUBB2B—Protein folding—TUBB4B—bone cancer	0.000429	0.00608	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000429	0.00608	CbGpPWpGaD
Vinorelbine—TUBB6—Protein folding—TUBB4B—bone cancer	0.000429	0.00608	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000425	0.00603	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000414	0.00587	CbGpPWpGaD
Vinorelbine—TUBB3—Protein folding—TUBB4B—bone cancer	0.000414	0.00587	CbGpPWpGaD
Vinorelbine—TUBB2B—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000406	0.00576	CbGpPWpGaD
Vinorelbine—TUBB6—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000406	0.00576	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000401	0.00569	CbGpPWpGaD
Vinorelbine—TUBB2A—Protein folding—TUBB4B—bone cancer	0.000401	0.00569	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000393	0.00556	CbGpPWpGaD
Vinorelbine—TUBB1—Protein folding—TUBB4B—bone cancer	0.000393	0.00556	CbGpPWpGaD
Vinorelbine—TUBB3—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000392	0.00556	CbGpPWpGaD
Vinorelbine—TUBB—Loss of Nlp from mitotic centrosomes—TUBB4B—bone cancer	0.000392	0.00555	CbGpPWpGaD
Vinorelbine—TUBB4A—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000387	0.00548	CbGpPWpGaD
Vinorelbine—TUBB1—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000372	0.00527	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.00037	0.00525	CbGpPWpGaD
Vinorelbine—TUBB6—Protein folding—TUBB2A—bone cancer	0.00037	0.00525	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.00037	0.00525	CbGpPWpGaD
Vinorelbine—TUBB2B—Protein folding—TUBB2A—bone cancer	0.00037	0.00525	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000367	0.0052	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000358	0.00507	CbGpPWpGaD
Vinorelbine—TUBB3—Protein folding—TUBB2A—bone cancer	0.000358	0.00507	CbGpPWpGaD
Vinorelbine—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000354	0.00502	CbGpPWpGaD
Vinorelbine—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000354	0.00502	CbGpPWpGaD
Vinorelbine—TUBB4A—Protein folding—TUBB4B—bone cancer	0.000352	0.00499	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000352	0.00499	CbGpPWpGaD
Vinorelbine—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000351	0.00497	CbGpPWpGaD
Vinorelbine—TUBB—Centrosome maturation—TUBB4B—bone cancer	0.000347	0.00491	CbGpPWpGaD
Vinorelbine—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000342	0.00484	CbGpPWpGaD
Vinorelbine—TUBB1—Protein folding—TUBB2A—bone cancer	0.000339	0.0048	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000339	0.0048	CbGpPWpGaD
Vinorelbine—TUBB4A—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000334	0.00473	CbGpPWpGaD
Vinorelbine—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000331	0.00469	CbGpPWpGaD
Vinorelbine—TUBB4A—Loss of Nlp from mitotic centrosomes—TUBB4B—bone cancer	0.000324	0.0046	CbGpPWpGaD
Vinorelbine—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000324	0.00459	CbGpPWpGaD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—TUBB4B—bone cancer	0.000318	0.00451	CbGpPWpGaD
Vinorelbine—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000305	0.00433	CbGpPWpGaD
Vinorelbine—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000305	0.00433	CbGpPWpGaD
Vinorelbine—TUBB4B—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000305	0.00433	CbGpPWpGaD
Vinorelbine—TUBB4A—Protein folding—TUBB2A—bone cancer	0.000304	0.00431	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000304	0.00431	CbGpPWpGaD
Vinorelbine—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000303	0.00429	CbGpPWpGaD
Vinorelbine—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000295	0.00418	CbGpPWpGaD
Vinorelbine—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000291	0.00412	CbGpPWpGaD
Vinorelbine—TUBB4A—Centrosome maturation—TUBB4B—bone cancer	0.000287	0.00407	CbGpPWpGaD
Vinorelbine—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000279	0.00396	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000278	0.00394	CbGpPWpGaD
Vinorelbine—TUBB4B—Protein folding—TUBB2A—bone cancer	0.000278	0.00394	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—TUBB4B—bone cancer	0.000264	0.00374	CbGpPWpGaD
Vinorelbine—TUBB6—Orphan transporters—TUBB4B—bone cancer	0.000258	0.00365	CbGpPWpGaD
Vinorelbine—TUBB2B—Orphan transporters—TUBB4B—bone cancer	0.000258	0.00365	CbGpPWpGaD
Vinorelbine—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000251	0.00356	CbGpPWpGaD
Vinorelbine—TUBB3—Orphan transporters—TUBB4B—bone cancer	0.000249	0.00353	CbGpPWpGaD
Vinorelbine—TUBB2A—Orphan transporters—TUBB4B—bone cancer	0.000241	0.00342	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—TUBB4B—bone cancer	0.000239	0.00339	CbGpPWpGaD
Vinorelbine—TUBB1—Orphan transporters—TUBB4B—bone cancer	0.000236	0.00334	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—TUBB4B—bone cancer	0.000236	0.00334	CbGpPWpGaD
Vinorelbine—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000229	0.00325	CbGpPWpGaD
Vinorelbine—TUBB2B—Orphan transporters—TUBB2A—bone cancer	0.000223	0.00315	CbGpPWpGaD
Vinorelbine—TUBB6—Orphan transporters—TUBB2A—bone cancer	0.000223	0.00315	CbGpPWpGaD
Vinorelbine—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000218	0.00309	CbGpPWpGaD
Vinorelbine—Vindesine—CYP3A4—bone cancer	0.000217	0.0604	CrCbGaD
Vinorelbine—TUBB3—Orphan transporters—TUBB2A—bone cancer	0.000215	0.00305	CbGpPWpGaD
Vinorelbine—TUBB4A—Orphan transporters—TUBB4B—bone cancer	0.000212	0.003	CbGpPWpGaD
Vinorelbine—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000206	0.00291	CbGpPWpGaD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000205	0.0029	CbGpPWpGaD
Vinorelbine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000204	0.0029	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000204	0.00289	CbGpPWpGaD
Vinorelbine—TUBB1—Orphan transporters—TUBB2A—bone cancer	0.000204	0.00288	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—TUBB4B—bone cancer	0.000198	0.00281	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—TUBB4B—bone cancer	0.000195	0.00277	CbGpPWpGaD
Vinorelbine—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—GSTP1—bone cancer	0.000188	0.00267	CbGpPWpGaD
Vinorelbine—TUBB4A—Orphan transporters—TUBB2A—bone cancer	0.000183	0.00259	CbGpPWpGaD
Vinorelbine—TUBB4B—Orphan transporters—TUBB2A—bone cancer	0.000167	0.00237	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000134	0.0019	CbGpPWpGaD
Vinorelbine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000126	0.00178	CbGpPWpGaD
Vinorelbine—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000119	0.00169	CbGpPWpGaD
Vinorelbine—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000118	0.00167	CbGpPWpGaD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000117	0.00166	CbGpPWpGaD
Vinorelbine—Thrombophlebitis—Epirubicin—bone cancer	0.000106	0.00188	CcSEcCtD
Vinorelbine—Pulmonary oedema—Doxorubicin—bone cancer	0.000104	0.00184	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—MOGS—bone cancer	0.000104	0.00148	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MOGS—bone cancer	0.000104	0.00148	CbGpPWpGaD
Vinorelbine—Hepatic failure—Epirubicin—bone cancer	0.000102	0.00181	CcSEcCtD
Vinorelbine—Sepsis—Doxorubicin—bone cancer	0.000102	0.0018	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—MOGS—bone cancer	0.000101	0.00143	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—ZW10—bone cancer	0.0001	0.00142	CbGpPWpGaD
Vinorelbine—Cerebrovascular accident—Methotrexate—bone cancer	0.0001	0.00177	CcSEcCtD
Vinorelbine—Lethargy—Methotrexate—bone cancer	0.0001	0.00177	CcSEcCtD
Vinorelbine—Ill-defined disorder—Cisplatin—bone cancer	0.0001	0.00177	CcSEcCtD
Vinorelbine—Anaemia—Cisplatin—bone cancer	9.97e-05	0.00176	CcSEcCtD
Vinorelbine—Phlebitis—Doxorubicin—bone cancer	9.88e-05	0.00175	CcSEcCtD
Vinorelbine—CYP2D6—Xenobiotics—CYP3A4—bone cancer	9.87e-05	0.0014	CbGpPWpGaD
Vinorelbine—Thrombophlebitis—Doxorubicin—bone cancer	9.84e-05	0.00174	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—MOGS—bone cancer	9.76e-05	0.00138	CbGpPWpGaD
Vinorelbine—Malaise—Cisplatin—bone cancer	9.73e-05	0.00172	CcSEcCtD
Vinorelbine—Leukopenia—Cisplatin—bone cancer	9.66e-05	0.00171	CcSEcCtD
Vinorelbine—Dermatitis bullous—Epirubicin—bone cancer	9.63e-05	0.0017	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—MOGS—bone cancer	9.55e-05	0.00135	CbGpPWpGaD
Vinorelbine—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	9.5e-05	0.00135	CbGpPWpGaD
Vinorelbine—Hepatic failure—Doxorubicin—bone cancer	9.47e-05	0.00167	CcSEcCtD
Vinorelbine—Cardiac failure—Epirubicin—bone cancer	9.43e-05	0.00167	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Epirubicin—bone cancer	9.39e-05	0.00166	CcSEcCtD
Vinorelbine—Lethargy—Epirubicin—bone cancer	9.39e-05	0.00166	CcSEcCtD
Vinorelbine—Hyponatraemia—Epirubicin—bone cancer	9.24e-05	0.00163	CcSEcCtD
Vinorelbine—Myalgia—Cisplatin—bone cancer	9.19e-05	0.00162	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	9.12e-05	0.00161	CcSEcCtD
Vinorelbine—Discomfort—Cisplatin—bone cancer	9.08e-05	0.0016	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—ZW10—bone cancer	8.97e-05	0.00127	CbGpPWpGaD
Vinorelbine—Dermatitis bullous—Doxorubicin—bone cancer	8.91e-05	0.00157	CcSEcCtD
Vinorelbine—Anaphylactic shock—Cisplatin—bone cancer	8.81e-05	0.00156	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	8.81e-05	0.00125	CbGpPWpGaD
Vinorelbine—Infection—Cisplatin—bone cancer	8.75e-05	0.00155	CcSEcCtD
Vinorelbine—Cardiac failure—Doxorubicin—bone cancer	8.72e-05	0.00154	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—bone cancer	8.69e-05	0.00153	CcSEcCtD
Vinorelbine—Lethargy—Doxorubicin—bone cancer	8.69e-05	0.00153	CcSEcCtD
Vinorelbine—Nervous system disorder—Cisplatin—bone cancer	8.64e-05	0.00153	CcSEcCtD
Vinorelbine—Thrombocytopenia—Cisplatin—bone cancer	8.62e-05	0.00152	CcSEcCtD
Vinorelbine—Blood creatinine increased—Epirubicin—bone cancer	8.62e-05	0.00152	CcSEcCtD
Vinorelbine—Tachycardia—Cisplatin—bone cancer	8.6e-05	0.00152	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—MOGS—bone cancer	8.57e-05	0.00121	CbGpPWpGaD
Vinorelbine—Skin disorder—Cisplatin—bone cancer	8.55e-05	0.00151	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—bone cancer	8.55e-05	0.00151	CcSEcCtD
Vinorelbine—Anorexia—Cisplatin—bone cancer	8.39e-05	0.00148	CcSEcCtD
Vinorelbine—Pancreatitis—Methotrexate—bone cancer	8.33e-05	0.00147	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—ZW10—bone cancer	8.32e-05	0.00118	CbGpPWpGaD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—bone cancer	8.29e-05	0.00146	CcSEcCtD
Vinorelbine—Hypotension—Cisplatin—bone cancer	8.23e-05	0.00145	CcSEcCtD
Vinorelbine—Vinblastine—CYP3A4—bone cancer	8.17e-05	0.0227	CrCbGaD
Vinorelbine—Muscular weakness—Epirubicin—bone cancer	8.12e-05	0.00143	CcSEcCtD
Vinorelbine—Pancytopenia—Methotrexate—bone cancer	8.07e-05	0.00143	CcSEcCtD
Vinorelbine—Vincristine—CYP3A4—bone cancer	8.04e-05	0.0223	CrCbGaD
Vinorelbine—Musculoskeletal discomfort—Cisplatin—bone cancer	8.02e-05	0.00142	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—bone cancer	7.98e-05	0.00141	CcSEcCtD
Vinorelbine—Dysphagia—Epirubicin—bone cancer	7.95e-05	0.00141	CcSEcCtD
Vinorelbine—Neutropenia—Methotrexate—bone cancer	7.95e-05	0.0014	CcSEcCtD
Vinorelbine—Paraesthesia—Cisplatin—bone cancer	7.91e-05	0.0014	CcSEcCtD
Vinorelbine—Dyspnoea—Cisplatin—bone cancer	7.85e-05	0.00139	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—MOGS—bone cancer	7.84e-05	0.00111	CbGpPWpGaD
Vinorelbine—Pancreatitis—Epirubicin—bone cancer	7.8e-05	0.00138	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—bone cancer	7.75e-05	0.00137	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	7.67e-05	0.00135	CcSEcCtD
Vinorelbine—Decreased appetite—Cisplatin—bone cancer	7.66e-05	0.00135	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—bone cancer	7.62e-05	0.00135	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—ZW10—bone cancer	7.61e-05	0.00108	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TUBB4B—bone cancer	7.61e-05	0.00108	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Cisplatin—bone cancer	7.6e-05	0.00134	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—bone cancer	7.58e-05	0.00134	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—bone cancer	7.58e-05	0.00134	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—bone cancer	7.55e-05	0.00133	CcSEcCtD
Vinorelbine—Pain—Cisplatin—bone cancer	7.53e-05	0.00133	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—bone cancer	7.51e-05	0.00133	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—bone cancer	7.44e-05	0.00131	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—ZW10—bone cancer	7.44e-05	0.00105	CbGpPWpGaD
Vinorelbine—Stomatitis—Methotrexate—bone cancer	7.39e-05	0.0013	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—bone cancer	7.36e-05	0.0013	CcSEcCtD
Vinorelbine—Feeling abnormal—Cisplatin—bone cancer	7.26e-05	0.00128	CcSEcCtD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	7.23e-05	0.00102	CbGpPWpGaD
Vinorelbine—Pancreatitis—Doxorubicin—bone cancer	7.21e-05	0.00127	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—bone cancer	7.2e-05	0.00127	CcSEcCtD
Vinorelbine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	7.19e-05	0.00102	CbGpPWpGaD
Vinorelbine—Angina pectoris—Doxorubicin—bone cancer	7.17e-05	0.00127	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—bone cancer	7.17e-05	0.00127	CcSEcCtD
Vinorelbine—Pneumonia—Epirubicin—bone cancer	7.13e-05	0.00126	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—bone cancer	7.09e-05	0.00125	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—bone cancer	7.09e-05	0.00125	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—bone cancer	7.07e-05	0.00125	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—bone cancer	6.99e-05	0.00123	CcSEcCtD
Vinorelbine—Body temperature increased—Cisplatin—bone cancer	6.96e-05	0.00123	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—bone cancer	6.95e-05	0.00123	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—bone cancer	6.91e-05	0.00122	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RFC1—bone cancer	6.9e-05	0.000977	CbGpPWpGaD
Vinorelbine—Neutropenia—Doxorubicin—bone cancer	6.88e-05	0.00122	CcSEcCtD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	6.85e-05	0.000971	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—ZW10—bone cancer	6.8e-05	0.000964	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TUBB4B—bone cancer	6.8e-05	0.000964	CbGpPWpGaD
Vinorelbine—Hepatobiliary disease—Epirubicin—bone cancer	6.71e-05	0.00118	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—bone cancer	6.66e-05	0.00118	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—bone cancer	6.64e-05	0.000941	CbGpPWpGaD
Vinorelbine—Agranulocytosis—Epirubicin—bone cancer	6.62e-05	0.00117	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—bone cancer	6.6e-05	0.00117	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—bone cancer	6.56e-05	0.00116	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—bone cancer	6.56e-05	0.00116	CcSEcCtD
Vinorelbine—Hypersensitivity—Cisplatin—bone cancer	6.49e-05	0.00115	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—bone cancer	6.43e-05	0.00114	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—bone cancer	6.4e-05	0.00113	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—bone cancer	6.33e-05	0.00112	CcSEcCtD
Vinorelbine—Asthenia—Cisplatin—bone cancer	6.32e-05	0.00112	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—bone cancer	6.31e-05	0.00112	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TUBB4B—bone cancer	6.3e-05	0.000893	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.29e-05	0.000892	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.29e-05	0.000892	CbGpPWpGaD
Vinorelbine—Connective tissue disorder—Epirubicin—bone cancer	6.26e-05	0.00111	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—bone cancer	6.21e-05	0.0011	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—bone cancer	6.17e-05	0.00109	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—RFC1—bone cancer	6.17e-05	0.000874	CbGpPWpGaD
Vinorelbine—Immune system disorder—Methotrexate—bone cancer	6.14e-05	0.00109	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—bone cancer	6.13e-05	0.00108	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—bone cancer	6.12e-05	0.00108	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.08e-05	0.000862	CbGpPWpGaD
Vinorelbine—Diarrhoea—Cisplatin—bone cancer	6.03e-05	0.00106	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—bone cancer	6.01e-05	0.00106	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—bone cancer	5.92e-05	0.00105	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—bone cancer	5.92e-05	0.00105	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—bone cancer	5.91e-05	0.00104	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—bone cancer	5.91e-05	0.00104	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.89e-05	0.000834	CbGpPWpGaD
Vinorelbine—Hypoaesthesia—Doxorubicin—bone cancer	5.86e-05	0.00104	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—bone cancer	5.79e-05	0.00102	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—bone cancer	5.78e-05	0.00102	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	5.76e-05	0.000816	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.76e-05	0.000816	CbGpPWpGaD
Vinorelbine—Immune system disorder—Epirubicin—bone cancer	5.75e-05	0.00102	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—bone cancer	5.74e-05	0.00101	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—bone cancer	5.73e-05	0.00101	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—TUBB4B—bone cancer	5.72e-05	0.000811	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—TUBB4B—bone cancer	5.72e-05	0.000811	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RFC1—bone cancer	5.71e-05	0.00081	CbGpPWpGaD
Vinorelbine—Arrhythmia—Epirubicin—bone cancer	5.69e-05	0.001	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—TUBB4B—bone cancer	5.63e-05	0.000799	CbGpPWpGaD
Vinorelbine—Alopecia—Epirubicin—bone cancer	5.63e-05	0.000994	CcSEcCtD
Vinorelbine—Vomiting—Cisplatin—bone cancer	5.6e-05	0.000989	CcSEcCtD
Vinorelbine—Rash—Cisplatin—bone cancer	5.55e-05	0.000981	CcSEcCtD
Vinorelbine—Dermatitis—Cisplatin—bone cancer	5.55e-05	0.00098	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—bone cancer	5.54e-05	0.000979	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—bone cancer	5.54e-05	0.000979	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—TUBB4B—bone cancer	5.52e-05	0.000783	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Methotrexate—bone cancer	5.49e-05	0.000971	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—bone cancer	5.47e-05	0.000967	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—bone cancer	5.47e-05	0.000966	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—bone cancer	5.47e-05	0.000966	CcSEcCtD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.43e-05	0.00077	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.43e-05	0.00077	CbGpPWpGaD
Vinorelbine—Back pain—Epirubicin—bone cancer	5.36e-05	0.000947	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—TUBB4B—bone cancer	5.35e-05	0.000758	CbGpPWpGaD
Vinorelbine—Angiopathy—Doxorubicin—bone cancer	5.34e-05	0.000944	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—bone cancer	5.34e-05	0.000943	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—bone cancer	5.32e-05	0.00094	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—bone cancer	5.32e-05	0.00094	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—bone cancer	5.31e-05	0.000938	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—bone cancer	5.3e-05	0.000936	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—bone cancer	5.26e-05	0.00093	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.25e-05	0.000744	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—TUBB4B—bone cancer	5.23e-05	0.000741	CbGpPWpGaD
Vinorelbine—Nausea—Cisplatin—bone cancer	5.23e-05	0.000924	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RFC1—bone cancer	5.23e-05	0.000741	CbGpPWpGaD
Vinorelbine—Alopecia—Doxorubicin—bone cancer	5.2e-05	0.00092	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.17e-05	0.000733	CbGpPWpGaD
Vinorelbine—Cough—Methotrexate—bone cancer	5.17e-05	0.000913	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—bone cancer	5.14e-05	0.000908	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—bone cancer	5.13e-05	0.000906	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—bone cancer	5.13e-05	0.000906	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—bone cancer	5.12e-05	0.000905	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—RFC1—bone cancer	5.11e-05	0.000724	CbGpPWpGaD
Vinorelbine—Arthralgia—Methotrexate—bone cancer	5.04e-05	0.000891	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—bone cancer	5.04e-05	0.000891	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—bone cancer	5.04e-05	0.000891	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	5.01e-05	0.000884	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—bone cancer	5e-05	0.000883	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—bone cancer	4.98e-05	0.00088	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—bone cancer	4.98e-05	0.00088	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.97e-05	0.000704	CbGpPWpGaD
Vinorelbine—Leukopenia—Epirubicin—bone cancer	4.96e-05	0.000876	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—bone cancer	4.96e-05	0.000876	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—TUBB2A—bone cancer	4.94e-05	0.0007	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—TUBB2A—bone cancer	4.94e-05	0.0007	CbGpPWpGaD
Vinorelbine—Palpitations—Epirubicin—bone cancer	4.9e-05	0.000865	CcSEcCtD
Vinorelbine—Cough—Epirubicin—bone cancer	4.84e-05	0.000854	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—bone cancer	4.83e-05	0.000854	CcSEcCtD
Vinorelbine—Infection—Methotrexate—bone cancer	4.8e-05	0.000848	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—bone cancer	4.78e-05	0.000845	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—TUBB2A—bone cancer	4.77e-05	0.000676	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Doxorubicin—bone cancer	4.76e-05	0.00084	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—bone cancer	4.74e-05	0.000837	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—bone cancer	4.74e-05	0.000837	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—bone cancer	4.73e-05	0.000836	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—bone cancer	4.72e-05	0.000833	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—bone cancer	4.72e-05	0.000833	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—bone cancer	4.72e-05	0.000833	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—TUBB4B—bone cancer	4.7e-05	0.000666	CbGpPWpGaD
Vinorelbine—Skin disorder—Methotrexate—bone cancer	4.69e-05	0.000829	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	4.69e-05	0.000828	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—RFC1—bone cancer	4.67e-05	0.000662	CbGpPWpGaD
Vinorelbine—Discomfort—Epirubicin—bone cancer	4.66e-05	0.000823	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—bone cancer	4.62e-05	0.000817	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—bone cancer	4.61e-05	0.000814	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—bone cancer	4.61e-05	0.000814	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—bone cancer	4.59e-05	0.000811	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—bone cancer	4.53e-05	0.000801	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—bone cancer	4.52e-05	0.000799	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—bone cancer	4.52e-05	0.000798	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—TUBB2A—bone cancer	4.52e-05	0.00064	CbGpPWpGaD
Vinorelbine—Infection—Epirubicin—bone cancer	4.49e-05	0.000794	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—bone cancer	4.47e-05	0.00079	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.46e-05	0.000632	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Epirubicin—bone cancer	4.44e-05	0.000784	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—bone cancer	4.43e-05	0.000782	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—bone cancer	4.43e-05	0.000782	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—bone cancer	4.41e-05	0.00078	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—bone cancer	4.4e-05	0.000778	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—bone cancer	4.39e-05	0.000776	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—bone cancer	4.37e-05	0.000771	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—bone cancer	4.37e-05	0.000771	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—bone cancer	4.37e-05	0.000771	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—bone cancer	4.34e-05	0.000767	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	4.34e-05	0.000766	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—bone cancer	4.31e-05	0.000762	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—bone cancer	4.31e-05	0.000762	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—bone cancer	4.31e-05	0.000761	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—DHFR—bone cancer	4.27e-05	0.000606	CbGpPWpGaD
Vinorelbine—Hypotension—Epirubicin—bone cancer	4.23e-05	0.000747	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—bone cancer	4.2e-05	0.000742	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—bone cancer	4.18e-05	0.000739	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—bone cancer	4.17e-05	0.000737	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—bone cancer	4.17e-05	0.000736	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—bone cancer	4.16e-05	0.000734	CcSEcCtD
Vinorelbine—Pain—Methotrexate—bone cancer	4.13e-05	0.00073	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—bone cancer	4.12e-05	0.000728	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—bone cancer	4.1e-05	0.000725	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	4.1e-05	0.000581	CbGpPWpGaD
Vinorelbine—Thrombocytopenia—Doxorubicin—bone cancer	4.1e-05	0.000724	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—bone cancer	4.08e-05	0.000722	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.08e-05	0.000578	CbGpPWpGaD
Vinorelbine—Skin disorder—Doxorubicin—bone cancer	4.06e-05	0.000718	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—bone cancer	4.06e-05	0.000717	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—TUBB2A—bone cancer	4.05e-05	0.000575	CbGpPWpGaD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	4.05e-05	0.000573	CbGpPWpGaD
Vinorelbine—Dyspnoea—Epirubicin—bone cancer	4.03e-05	0.000712	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—bone cancer	3.99e-05	0.000705	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—bone cancer	3.98e-05	0.000704	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—bone cancer	3.95e-05	0.000698	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—bone cancer	3.93e-05	0.000695	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—bone cancer	3.91e-05	0.000691	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—bone cancer	3.9e-05	0.00069	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—bone cancer	3.9e-05	0.000689	CcSEcCtD
Vinorelbine—Pain—Epirubicin—bone cancer	3.87e-05	0.000683	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—bone cancer	3.87e-05	0.000683	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—bone cancer	3.84e-05	0.000678	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—DHFR—bone cancer	3.82e-05	0.000542	CbGpPWpGaD
Vinorelbine—Abdominal pain—Methotrexate—bone cancer	3.82e-05	0.000675	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—bone cancer	3.82e-05	0.000675	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—bone cancer	3.81e-05	0.000674	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—bone cancer	3.76e-05	0.000664	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—bone cancer	3.73e-05	0.000659	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—bone cancer	3.73e-05	0.000658	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—TUBB2A—bone cancer	3.71e-05	0.000526	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Epirubicin—bone cancer	3.7e-05	0.000653	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—bone cancer	3.64e-05	0.000643	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—bone cancer	3.61e-05	0.000638	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—bone cancer	3.61e-05	0.000637	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—bone cancer	3.59e-05	0.000635	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—bone cancer	3.58e-05	0.000632	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—bone cancer	3.58e-05	0.000632	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—bone cancer	3.58e-05	0.000632	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—bone cancer	3.58e-05	0.000632	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—bone cancer	3.56e-05	0.000629	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—DHFR—bone cancer	3.54e-05	0.000502	CbGpPWpGaD
Vinorelbine—Asthenia—Methotrexate—bone cancer	3.47e-05	0.000613	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—bone cancer	3.45e-05	0.000609	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—EIF2S1—bone cancer	3.44e-05	0.000488	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—EIF2S1—bone cancer	3.44e-05	0.000488	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Doxorubicin—bone cancer	3.42e-05	0.000605	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—bone cancer	3.42e-05	0.000604	CcSEcCtD
Vinorelbine—Hypersensitivity—Epirubicin—bone cancer	3.33e-05	0.000589	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—EIF2S1—bone cancer	3.33e-05	0.000471	CbGpPWpGaD
Vinorelbine—Urticaria—Doxorubicin—bone cancer	3.32e-05	0.000587	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.32e-05	0.000471	CbGpPWpGaD
Vinorelbine—Abdominal pain—Doxorubicin—bone cancer	3.31e-05	0.000584	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—bone cancer	3.31e-05	0.000584	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—bone cancer	3.31e-05	0.000584	CcSEcCtD
Vinorelbine—Asthenia—Epirubicin—bone cancer	3.24e-05	0.000573	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—DHFR—bone cancer	3.24e-05	0.000459	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—EIF2S1—bone cancer	3.22e-05	0.000457	CbGpPWpGaD
Vinorelbine—Pruritus—Epirubicin—bone cancer	3.2e-05	0.000565	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—bone cancer	3.2e-05	0.000565	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CHEK2—bone cancer	3.19e-05	0.000453	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—DHFR—bone cancer	3.17e-05	0.000449	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—EIF2S1—bone cancer	3.15e-05	0.000446	CbGpPWpGaD
Vinorelbine—Diarrhoea—Epirubicin—bone cancer	3.09e-05	0.000547	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—bone cancer	3.08e-05	0.000545	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—bone cancer	3.07e-05	0.000543	CcSEcCtD
Vinorelbine—Rash—Methotrexate—bone cancer	3.05e-05	0.000538	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—bone cancer	3.04e-05	0.000538	CcSEcCtD
Vinorelbine—Headache—Methotrexate—bone cancer	3.03e-05	0.000535	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—bone cancer	3e-05	0.00053	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—bone cancer	2.99e-05	0.000528	CcSEcCtD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	2.99e-05	0.000423	CbGpPWpGaD
Vinorelbine—Pruritus—Doxorubicin—bone cancer	2.96e-05	0.000523	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—DHFR—bone cancer	2.9e-05	0.000411	CbGpPWpGaD
Vinorelbine—Vomiting—Epirubicin—bone cancer	2.88e-05	0.000508	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—bone cancer	2.87e-05	0.000507	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—bone cancer	2.86e-05	0.000506	CcSEcCtD
Vinorelbine—Rash—Epirubicin—bone cancer	2.85e-05	0.000504	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—bone cancer	2.85e-05	0.000503	CcSEcCtD
Vinorelbine—Headache—Epirubicin—bone cancer	2.83e-05	0.000501	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—EIF2S1—bone cancer	2.83e-05	0.000401	CbGpPWpGaD
Vinorelbine—Dizziness—Doxorubicin—bone cancer	2.77e-05	0.000489	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—BRCA2—bone cancer	2.71e-05	0.000384	CbGpPWpGaD
Vinorelbine—Nausea—Epirubicin—bone cancer	2.69e-05	0.000475	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—bone cancer	2.66e-05	0.00047	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—CHEK2—bone cancer	2.65e-05	0.000375	CbGpPWpGaD
Vinorelbine—Rash—Doxorubicin—bone cancer	2.64e-05	0.000466	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—bone cancer	2.64e-05	0.000466	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—bone cancer	2.62e-05	0.000463	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—EIF2S1—bone cancer	2.59e-05	0.000367	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—bone cancer	2.49e-05	0.000439	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	2.44e-05	0.000346	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CHEK2—bone cancer	2.42e-05	0.000343	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK4—bone cancer	2.25e-05	0.000318	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—BRCA2—bone cancer	2.24e-05	0.000318	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	2.08e-05	0.000295	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—BRCA2—bone cancer	2.05e-05	0.000291	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK4—bone cancer	2.01e-05	0.000285	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RB1—bone cancer	1.95e-05	0.000277	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.89e-05	0.000268	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK4—bone cancer	1.86e-05	0.000264	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	1.77e-05	0.00025	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RB1—bone cancer	1.75e-05	0.000247	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	1.74e-05	0.000247	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.72e-05	0.000244	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK4—bone cancer	1.7e-05	0.000241	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.7e-05	0.000241	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK4—bone cancer	1.66e-05	0.000236	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RB1—bone cancer	1.62e-05	0.000229	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	1.61e-05	0.000228	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.52e-05	0.000216	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDK4—bone cancer	1.52e-05	0.000216	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTP1—bone cancer	1.51e-05	0.000214	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	1.49e-05	0.000211	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MDM2—bone cancer	1.49e-05	0.000211	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RB1—bone cancer	1.48e-05	0.00021	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RB1—bone cancer	1.45e-05	0.000205	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.44e-05	0.000204	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.44e-05	0.000204	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP2—bone cancer	1.41e-05	0.0002	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP2—bone cancer	1.41e-05	0.0002	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP2—bone cancer	1.36e-05	0.000193	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RB1—bone cancer	1.32e-05	0.000188	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP2—bone cancer	1.32e-05	0.000187	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP2—bone cancer	1.29e-05	0.000183	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.24e-05	0.000176	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MDM2—bone cancer	1.23e-05	0.000175	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP2—bone cancer	1.16e-05	0.000164	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MDM2—bone cancer	1.13e-05	0.00016	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NDUFA12—bone cancer	1.12e-05	0.000159	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.07e-05	0.000151	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NDUFA12—bone cancer	1.06e-05	0.00015	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP2—bone cancer	1.06e-05	0.00015	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTP1—bone cancer	9.87e-06	0.00014	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	9.74e-06	0.000138	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NT5C3A—bone cancer	9.31e-06	0.000132	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NT5C3A—bone cancer	8.77e-06	0.000124	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—bone cancer	8.54e-06	0.000121	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	7.92e-06	0.000112	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	7.63e-06	0.000108	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—bone cancer	7.08e-06	0.0001	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NDUFA12—bone cancer	6.92e-06	9.81e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	6.88e-06	9.76e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—bone cancer	6.47e-06	9.17e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NT5C3A—bone cancer	5.73e-06	8.13e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	5.41e-06	7.67e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.54e-06	6.44e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ENO2—bone cancer	4.08e-06	5.78e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ENO2—bone cancer	3.84e-06	5.44e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—DHFR—bone cancer	3.78e-06	5.36e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—DHFR—bone cancer	3.56e-06	5.05e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GNA11—bone cancer	3.53e-06	5.01e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GNA11—bone cancer	3.33e-06	4.72e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP3A4—bone cancer	3.2e-06	4.54e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP3A4—bone cancer	3.02e-06	4.28e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—bone cancer	2.74e-06	3.88e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—bone cancer	2.58e-06	3.66e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ENO2—bone cancer	2.51e-06	3.56e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—DHFR—bone cancer	2.33e-06	3.3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GNA11—bone cancer	2.18e-06	3.09e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—bone cancer	1.69e-06	2.39e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—bone cancer	1.42e-06	2.01e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—bone cancer	1.34e-06	1.9e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—bone cancer	8.75e-07	1.24e-05	CbGpPWpGaD
